GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $258,000 | +7.9% | 6,121 | -1.4% | 0.02% | 0.0% |
| Q4 2016 | $239,000 | -18.7% | 6,211 | -8.7% | 0.02% | -19.0% |
| Q3 2016 | $294,000 | +10.9% | 6,806 | +11.2% | 0.02% | +5.0% |
| Q2 2016 | $265,000 | +2.7% | 6,121 | -3.7% | 0.02% | +5.3% |
| Q1 2016 | $258,000 | -10.1% | 6,353 | -10.7% | 0.02% | -9.5% |
| Q4 2015 | $287,000 | -96.7% | 7,118 | -96.6% | 0.02% | -95.6% |
| Q2 2015 | $8,651,000 | -11.2% | 207,696 | -1.7% | 0.48% | +10.6% |
| Q1 2015 | $9,746,000 | +3.3% | 211,188 | -4.3% | 0.44% | +1.9% |
| Q4 2014 | $9,432,000 | -17.5% | 220,674 | -11.3% | 0.43% | -16.1% |
| Q3 2014 | $11,433,000 | -10.9% | 248,698 | +3.6% | 0.51% | -8.8% |
| Q2 2014 | $12,835,000 | +2.7% | 240,005 | +2.6% | 0.56% | -2.1% |
| Q1 2014 | $12,500,000 | +4.0% | 233,946 | +4.0% | 0.57% | +8.8% |
| Q4 2013 | $12,014,000 | +10.9% | 225,018 | +4.2% | 0.52% | +1.2% |
| Q3 2013 | $10,831,000 | +3.0% | 215,881 | +2.6% | 0.52% | -2.8% |
| Q2 2013 | $10,512,000 | – | 210,369 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |